Bill Detail

S. 1387

Congress: 119

Title

National Biotechnology Initiative Act of 2025

Summary

National Biotechnology Initiative Act of 2025 This bill establishes an interagency biotechnology initiative to coordinate and advance federal biotechnology activities, including research, product regulation, and national security efforts. The bill implements several recommendations issued by the National Security Commission on Emerging Biotechnology in its April 2025 final report. Under the bill, agencies participating in the initiative must conduct or support biotechnology-related activities in coordination with the initiative, such as (1) supporting the development and commercialization of biotechnology products, (2) coordinating with industry on threat information sharing and risk mitigation, and (3) supporting the development of a domestic biotechnology workforce. Further, the bill provides for an executive office and interagency committee to coordinate and support initiative activities. Among other functions, the office must assess and address national security, economic security, and biosafety issues associated with emerging biotechnology; coordinate support for biotechnology research and development, including by supporting a national network of biotechnology testbeds; negotiate interagency agreements to establish clear regulatory pathways for biotechnology products; and develop an outreach strategy to improve international market access for U.S. biotechnology products. The office and committee must jointly publish a website with information about federal biotechnology activities and must periodically publish and submit to Congress a comprehensive national strategy for biotechnology. The Government Accountability Office must periodically review and report to Congress on the activities of the office and committee. The office must wind down and transition most of its functions to the committee after 20 years.

Sponsor

Sen. Todd Young [R-IN]

Status

Committee on Health, Education, Labor, and Pensions. Hearings held.

Status as of Nov 13, 2026, 7:00 AM · synced 3d ago

Introduced

2025-04-09

Data source mode: congress-gov

Bill Engagement

Lobbyists on the case

1 org · 3 lobbyists · 1 filing mention S. 1387 (National Biotechnology Initiative Act of 2025) in LDA disclosures.

These are cached disclosure mentions, not verified current representation or confirmed event attendance.

Top orgs filing
Lobbyists on this bill
+ 1 more in the full intelligence view

Limited preview · paid intelligence

Keep the intelligence current—not just this one record.

Unlock every organization and lobbyist filing on this bill, the complete event and issue map, private team positions, and recurring movement alerts across the portfolio.

Federal Intelligence is $2,500 one-time for three months, or $9,000 for twelve months prepaid, for one named user. Full tracked federal calendar, connected organization/bill/disclosure research, and a private workspace. Fixed terms; no automatic renewal. No demo or scope email is required for standard access.

Buy Federal Intelligence · $2,500 for 3 monthsRequest a Sample by EmailPrefer a walkthrough first?Already a customer? Sign inGet free intelligence alerts →

After verified successful payment, access is activated within one business day and a secure setup link is emailed. Your term starts at activation. These links do not charge you or unlock records. A free alert subscription does not grant full access.